Immuneering IMRX
NASDAQ IMRX
$3.76 +0.11 (+2.88%)
As of: Nov 10, 2026 · 1:32 PM EST

Immuneering (IMRX) Total Current Liabilities (2020 - 2026)

Updated

Immuneering's Total Current Liabilities was $10.79 million in Q3 2026, up 13.1% from $9.55 million a year earlier and up 33.0% from the prior quarter.

Analysis

Immuneering (IMRX) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Immuneering came in at $10.07 million, up 34.2% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 34.9% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $7.5 million in FY2024 (-4.4%), $7.85 million in FY2023 (-2.6%), $8.05 million in FY2022 (+43.0%) and $5.63 million in FY2021 (+149.7%).
  • The Q3 2026 figure marks the highest quarterly Total Current Liabilities in data going back to Q4 2020.
  • Compared with a year earlier, Total Current Liabilities was higher in five of the last eight quarters, with growth averaging 12.0%.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q4 2021 (growth of 149.7%); the worst was Q3 2023 (a decline of 22.5%).
  • Per Business Quant data, IMRX's Total Current Liabilities in the three quarters before Q3 2026 was $8.12 million (Q2 2026), $4.97 million (Q1 2026) and $10.07 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 55.46 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 43.10 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 31.55 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 12.00 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 31.73 Bn
10 Immuneering 246.36 Mn -378.47 Mn - 10.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.79 Mn
Jun 30, 2026 8.12 Mn
Mar 31, 2026 4.97 Mn
Dec 31, 2025 10.07 Mn
Sep 30, 2025 9.55 Mn
Jun 30, 2025 7.49 Mn
Mar 31, 2025 5.11 Mn
Dec 31, 2024 7.50 Mn
Sep 30, 2024 6.92 Mn
Jun 30, 2024 6.78 Mn
Mar 31, 2024 5.18 Mn
Dec 31, 2023 7.85 Mn
Sep 30, 2023 5.62 Mn
Jun 30, 2023 5.48 Mn
Mar 31, 2023 5.53 Mn
Dec 31, 2022 8.05 Mn
Sep 30, 2022 7.26 Mn
Jun 30, 2022 3.80 Mn
Mar 31, 2022 3.67 Mn
Dec 31, 2021 5.63 Mn
API Access

Immuneering Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IMRX&period=max&api_key=YOUR_API_KEY